Early clinical results for Pfizer's acquired obesity drug PF-3944 show it may fall short of the high bar set by market leaders, raising questions about its competitive edge in the lucrative weight-loss market.
Somaliland's President tells Reuters he anticipates a swift trade agreement with Israel, the first nation to recognize its independence, with critical minerals like lithium on the table in exchange for technology and investment.
French prosecutors have urged an appeals court to confirm a ruling that found far-right officials guilty of misusing EU funds, a decision that could bar Marine Le Pen from next year's presidential race.
Israeli Prime Minister Benjamin Netanyahu convened with senior U.S. diplomat Steve Witkoff and top Israeli security officials on Tuesday, as Washington and Tehran prepare for a critical round of nuclear negotiations in Turkey this Friday.
French cybercrime prosecutors searched X's Paris headquarters, expanding an investigation into Grok AI over alleged deepfake pornography, Holocaust denial, and data violations. The probe coincides with regulatory actions in Britain and the EU.
NATO's military command has begun planning an 'Arctic Sentry' surveillance mission as U.S.-European tensions over Greenland's future strain alliance unity, officials confirmed Tuesday.
Britain's Information Commissioner's Office has opened a formal investigation into X and its AI chatbot Grok, focusing on the alleged use of personal data to create non-consensual sexualized imagery, including of minors.
A Delta Air Lines flight from New York to Tel Aviv was forced to make an unscheduled landing in Dublin after declaring a general emergency over the Irish Sea. The Airbus A330-900 performed a 'heavyweight landing' due to its full fuel tanks, adding complexity to the incident.
Legend Biotech shares have plummeted nearly 50% in three months, erasing billions in market value and forcing investors to question whether the selloff is an overreaction or a prudent reassessment of the CAR-T leader's long-term prospects.
Digital asset markets face a significant liquidity squeeze, with Bitcoin breaking from tech stocks and institutional players stepping in amid a wave of regulatory developments and macroeconomic uncertainty.
Foran Mining (TSX:FOM) has delivered staggering returns to investors over the long term, yet a recent pullback and a stark DCF valuation model raise critical questions. Is the current price a buying opportunity or a sign of overheating? We examine the numbers and the narratives shaping this junior miner's story.
ASML Holding's share price has soared 74% over the past year, fueled by relentless demand for its advanced chipmaking equipment. As the stock trades near record highs, investors are grappling with a critical question: has the market gotten ahead of itself, or is this just the beginning?
Debra K. Osteen's return to the helm of Acadia Healthcare coincides with mounting pressure from activist investor Engine Capital for a strategic review, setting the stage for a pivotal period that could reshape the behavioral health giant's future.
Merck & Co. reported solid Q4 2025 results but issued a cautious 2026 sales forecast, citing acquisition costs and patent expirations. Despite this, shares rose as the market focused on the company's sustained dividend and aggressive reinvestment in its oncology and vaccine pipelines.
Siemens Energy's fair value estimate has been revised upward by analysts, reflecting a more optimistic outlook driven by stronger demand signals, though questions over operational execution continue to temper expectations.
Fresh analyst coverage has reignited debate around Crescent Energy (CRGY), with some firms highlighting a significant gap between its current share price and estimated fair value. While recent momentum is positive, the stock's lofty valuation and sector-wide pressures present a complex risk-reward picture for investors.
A stronger-than-expected January for Macau's casino sector has lifted shares in Wynn Macau, but analysts are divided on whether the stock's current price fully reflects its growth prospects or still holds value.
Moderna forges a key partnership with Recordati to advance a therapy for propionic acidemia, while appointing a new Chief Development Officer as part of its strategic expansion beyond its COVID-19 vaccine roots.
The parcel carrier Veho is launching a novel service that allows online retailers to slash shipping costs by opting for flexible delivery windows, challenging the industry's rigid speed paradigm and offering a new tool in the fight against rising last-mile expenses.
Crude prices are swinging on a pendulum of geopolitical risk, with former President Trump's statements on Iran and a looming US-India trade deal creating waves of uncertainty that overshadow fundamental supply data, prompting record speculative interest.
